Detalhe da pesquisa
1.
A Comparative Phase I Study of Combination, Homologous Subtype-C DNA, MVA, and Env gp140 Protein/Adjuvant HIV Vaccines in Two Immunization Regimes.
Front Immunol
; 8: 149, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28275375
2.
A Phase 1 Human Immunodeficiency Virus Vaccine Trial for Cross-Profiling the Kinetics of Serum and Mucosal Antibody Responses to CN54gp140 Modulated by Two Homologous Prime-Boost Vaccine Regimens.
Front Immunol
; 8: 595, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28596770
3.
Adenovirus-based HIV-1 vaccine candidates tested in efficacy trials elicit CD8+ T cells with limited breadth of HIV-1 inhibition.
AIDS
; 30(11): 1703-12, 2016 07 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-27088318
4.
Broad HIV-1 inhibition in vitro by vaccine-elicited CD8(+) T cells in African adults.
Mol Ther Methods Clin Dev
; 3: 16061, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27617268
5.
In vivo electroporation enhances the immunogenicity of an HIV-1 DNA vaccine candidate in healthy volunteers.
PLoS One
; 6(5): e19252, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21603651